Verition Fund Management LLC Edwards Lifesciences Corp Transaction History

Verition Fund Management LLC

$13 Billion
Q1 2024

A detailed history of Verition Fund Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Verition Fund Management LLC holds 17,493 shares of EW stock, worth $1.62 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,493

Previous 17,765 1.53%

Holding current value

$1.62 Million

Previous $1.35 Million 23.41%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $19,730 - $25,992	-272 Reduced 1.53%	17,493 $1.67 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $1.1 Million - $1.38 Million	17,765 New	17,765 $1.35 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $381,993 - $434,719	-5,144 Reduced 57.87%	3,745 $309,000
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $2.35 Million - $3.01 Million	-34,425 Reduced 79.48%	8,889 $663,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $3.57 Million - $4.65 Million	43,314 New	43,314 $3.58 Million

Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $1.14 Million - $1.4 Million	10,747 Added 174.66%	16,900 $2.19 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $633,205 - $755,280	6,153 New	6,153 $697,000
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $411,570 - $514,266	-4,909 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$78.68 - $90.67 $386,240 - $445,099	4,909 New	4,909 $410,000
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $559,755 - $712,323	-7,808 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $669,682 - $871,514	-9,967 Reduced 56.07%	7,808 $623,000
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.02 Million - $1.37 Million	17,775 New	17,775 $1.23 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $368,599 - $569,673	-7,033 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $504,266 - $577,338	7,033 New	7,033 $1.64 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $213,024 - $261,063	-3,461 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $192,916 - $222,923	3,461 New	3,461 $639,000
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $62,927 - $84,161	-1,314 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $60,982 - $74,819	1,314 New	1,314 $201,000
Q3 2018 Nov 15, 2018	SELL	$45.7 - $58.03 $192,579 - $244,538	-4,214 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$42.45 - $51.3 $178,884 - $216,178	4,214 New	4,214 $613,000
Q1 2018 May 16, 2018	SELL	$37.19 - $47.45 $419,763 - $535,568	-11,287 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$33.79 - $39.39 $89,205 - $103,989	-2,640 Reduced 18.96%	11,287 $1.27 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $505,410 - $540,785	13,927	13,927 $1.52 Million

Others Institutions Holding EW

# of Institutions

1,375

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Edwards Lifesciences Corp Transaction History